October 24, 2022 Jill Mullan Re: Separation Agreement Dear Jill,iSpecimen Inc. • October 28th, 2022 • Services-commercial physical & biological research • Massachusetts
Company FiledOctober 28th, 2022 Industry JurisdictionThis letter sets forth the substance of the separation agreement (the “Agreement”) which ISPECIMEN INC. (the “Company”) is offering to you to aid in your employment transition.
iSpecimen, Inc. FIRST AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • October 28th, 2022 • iSpecimen Inc. • Services-commercial physical & biological research • Massachusetts
Contract Type FiledOctober 28th, 2022 Company Industry JurisdictionThis Amended and Restated Executive Employment Agreement (the “Agreement”) made as of this 24th day of October, 2022, between Benjamin Bielak (the “Executive”), and iSpecimen, Inc., a Delaware corporation located at 450 Bedford St, Lexington, MA 02420 (the “Company”).
iSpecimen, Inc. FIRST RESTATED NONCOMPETITION, NONSOLICITATION, NONDISCLOSURE AND INVENTIONS AGREEMENTiSpecimen Inc. • October 28th, 2022 • Services-commercial physical & biological research • Massachusetts
Company FiledOctober 28th, 2022 Industry JurisdictionThe undersigned, TRACY WILSON CURLEY, in consideration for and as a condition of employment as a senior executive officer (the “Executive”) of iSpecimen, Inc. (the “Company”), or for receiving stock or options, or any other form of compensation, salary, bonus, benefit or fringe benefits from or in the Company, and in connection with executing an Employment Agreement with the Company, hereby agrees with the Company as follows:
iSpecimen, Inc. FIRST RESTATED NONCOMPETITION, NONSOLICITATION, NONDISCLOSURE AND INVENTIONS AGREEMENTNondisclosure and Inventions Agreement • October 28th, 2022 • iSpecimen Inc. • Services-commercial physical & biological research • Massachusetts
Contract Type FiledOctober 28th, 2022 Company Industry JurisdictionThe undersigned, BENJAMIN BIELAK, in consideration for and as a condition of employment as a senior executive officer (the “Executive”) of iSpecimen, Inc. (the “Company”), or for receiving stock or options, or any other form of compensation, salary, bonus, benefit or fringe benefits from or in the Company, and in connection with executing an Employment Agreement with the Company, hereby agrees with the Company as follows: